Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 500 entries
View as:

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

Phase: N/A Priority: Normal
NCT ID: NCT04626596 Org: User:
Start: 11/19/20 End: 12/30/24 Due: 12/30/25

A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)

Phase: N/A Priority: Normal
NCT ID: NCT01408615 Org: User:
Start: 09/20/11 End: 11/18/16 Due: 11/18/17

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

Phase: N/A Priority: Normal
NCT ID: NCT00151424 Org: User:
Start: 02/15/05 End: 02/06/06 Due: 02/06/07

Montelukast Back to School Asthma Study (0476-340)

Phase: N/A Priority: Normal
NCT ID: NCT00461032 Org: User:
Start: 06/30/06 End: 11/30/06 Due: 11/30/07

A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)

Phase: N/A Priority: Normal
NCT ID: NCT01386125 Org: User:
Start: 06/30/11 End: 02/28/13 Due: 02/28/14

Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

Phase: N/A Priority: Normal
NCT ID: NCT00779636 Org: User:
Start: 07/01/03 End: 11/01/04 Due: 11/01/05

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

Phase: N/A Priority: Normal
NCT ID: NCT01098110 Org: User:
Start: 05/25/10 End: 04/14/14 Due: 04/14/15

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

Phase: N/A Priority: Normal
NCT ID: NCT01350934 Org: User:
Start: 06/19/11 End: 01/10/13 Due: 01/10/14

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01370590 Org: User:
Start: 09/30/11 End: 04/30/12 Due: 04/30/13

Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

Phase: N/A Priority: Normal
NCT ID: NCT00652717 Org: User:
Start: 02/01/05 End: 08/04/05 Due: 08/04/06

An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

Phase: N/A Priority: Normal
NCT ID: NCT01599494 Org: User:
Start: 03/31/14 End: 06/30/15 Due: 06/30/16

Cozaar XQ Re-examination Study (MK-0954-349)

Phase: N/A Priority: Normal
NCT ID: NCT01041807 Org: User:
Start: 02/28/10 End: 03/31/15 Due: 03/31/16

Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00409773 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)

Phase: N/A Priority: Normal
NCT ID: NCT02748057 Org: User:
Start: 05/18/16 End: 12/11/17 Due: 12/11/18

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)

Phase: N/A Priority: Normal
NCT ID: NCT02668822 Org: User:
Start: 02/09/16 End: 09/12/16 Due: 09/12/17

Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)

Phase: N/A Priority: Normal
NCT ID: NCT00413972 Org: User:
Start: 04/30/06 End: 11/30/06 Due: 11/30/07

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00598208 Org: User:
Start: 05/19/03 End: 03/15/04 Due: 03/15/05

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

Phase: N/A Priority: Normal
NCT ID: NCT00552097 Org: User:
Start: 06/01/02 End: 04/25/06 Due: 04/25/07

Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)

Phase: N/A Priority: Normal
NCT ID: NCT01142596 Org: User:
Start: 05/25/10 End: 04/22/15 Due: 04/22/16

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Phase: N/A Priority: Normal
NCT ID: NCT01077817 Org: User:
Start: 02/26/10 End: 02/16/12 Due: 02/16/13

A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00480662 Org: User:
Start: 10/31/01 End: 10/31/02 Due: 10/31/03

Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)

Phase: N/A Priority: Normal
NCT ID: NCT00431431 Org: User:
Start: 07/31/00 End: 02/15/05 Due: 02/15/06

Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)

Phase: N/A Priority: Normal
NCT ID: NCT00751075 Org: User:
Start: 12/01/03 End: 06/22/04 Due: 06/22/05

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092781 Org: User:
Start: 03/01/04 End: 02/01/05 Due: 02/01/06

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00276458 Org: User:
Start: 02/28/06 End: 01/31/08 Due: 01/31/09